Hospital stocks experienced significant selling pressure for the second consecutive trading session, with shares falling up to 7% on Wednesday's intra-day deals. According to reports from Business Standard, Dr. Agarwals Health Care and Fortis Healthcare were the worst performers, declining 7% and 6% respectively. Other major hospital companies including Max Healthcare Institute, Aster DM Quality Care, Apollo Hospitals Enterprise, Artemis Medicare Services, Shalby, and Global Health (Medanta) traded in the range of 2% to 3% lower. As per Informist, at 1254 IST, shares of Max Healthcare Institute, Yatharth Hospital & Trauma Care Services, Global Health, Apollo Hospitals Enterprise traded 2.2-2.9% lower, while Fortis Healthcare and Aster DM Quality Care were down 1% and 1.5% respectively. On Tuesday, Max Health and Apollo Hospitals ended lower following recommendations by a parliamentary panel on hospital price caps, as reported by CNBC TV18.
The decline was triggered by a Parliamentary Standing Committee's recommendation to benchmark private hospital room charges against prevailing three-star hotel tariffs. As reported by Business Standard, the panel introduced fixed package rates for standard medical and surgical procedures while strengthening transparency in hospital billing. The committee noted that average hospitalization costs in private hospitals stood at ₹50,508 compared with ₹6,631 in government hospitals, while average childbirth expenses were ₹37,630 versus ₹2,299 respectively. The committee recommended that private hospitals in large metropolitan cities should cap room charges at the average tariff of three-star hotels in the area around the hospital. According to Informist, the ceiling would apply to the basic room tariff, with hospitals allowed to add the cost of resident doctors, nursing, disposable consumables, meals and laundry separately. The panel also recommended private and public healthcare institutions to formulate and publicly display fixed package rates for standard surgical and medical procedures, including surgeon fees, diagnostic investigations, consumables and standard post-operative care.
India is weighing wide-ranging health insurance reforms as part of efforts to address medical inflation of 12% to 14% annually, according to sources familiar with the matter. The reforms envisage a common health insurance product that all insurers will be required to offer alongside existing plans, aiming to standardise coverage and rates for a range of illnesses and procedures. The widely varied rates and coverage now on offer from providers prompt consumers to switch policies more often in search of the best deal. The committee will also push for wider adoption of the National Health Claims Exchange, a platform developed by India's health ministry and the insurance regulator, which would offer hospitals and insurers a common format to share claims and billing data. As per Policybazaar's chief business officer Amit Chhabra, the common exchange can significantly speed up time to settle claims at the time of discharge. Industry estimates suggest 10% to 15% of health claims are unwarranted or fraudulent, prompting authorities to focus on standardising pricing and coverage.
The hospital sector decline occurred amid broader market weakness, with the Nifty falling 112 points to 24,472 and the Sensex declining 388 points to 78,154 on Tuesday. According to CNBC TV18, the Nifty Bank index slipped 241 points to 57,446, while the Midcap index fell 12 points to 63,843. The institutional activity showed a reversal from Monday, when FIIs remained net buyers with purchases exceeding sales by ₹1,974.76 crore, while DIIs were net sellers of ₹1,290.29 crore. On Tuesday, FIIs bought equities worth ₹14,628.47 crore and sold shares worth ₹14,369.92 crore, resulting in net buying of ₹258.55 crore, while DIIs bought ₹15,006.72 crore and sold ₹14,981.95 crore, resulting in net buying of ₹24.77 crore. The combined net buying by FIIs and DIIs stood at ₹283.32 crore on Tuesday.
According to Business Standard, at 2 PM on Wednesday, the BSE Hospital index was the top loser among sectoral indices, down 3%, compared to a 0.77% decline in the BSE Sensex. The BSE Hospital index has dipped 4.4% over the past two trading days, highlighting the sustained pressure on the sector. The committee also recommended reviewing foreign direct investment norms related to operational control and acquisitions in private hospitals while encouraging foreign investment in medical devices, consumables, and pharmaceutical manufacturing. As per Informist, the committee also recommended the government to review and rationalise foreign direct investment limits in the operational management of private hospital chains. Reform recommendations are expected by year-end from a panel of regulators, industry leaders, hospitals and the Confederation of Indian Industry (CII) group, with implementation to be rolled out later. India wants more of its population of 1.4 billion to invest in insurance, where such spending stands at less than 4% of GDP as compared to a global average in excess of 7%.
